Financhill
Back

Puma Biotechnology Quote, Financials, Valuation and Earnings

Puma Biotechnology Price Quote

$4.88
+0.02 (+-1.21%)
(Updated: May 4, 2024 at 6:31 AM ET)

Puma Biotechnology Key Stats

Sell
45
Puma Biotechnology (PBYI) is a Sell

Day range:
$4.81 - $5.26
52-week range:
$2.13 - $7.73
Dividend yield:
0%
P/E ratio:
10.80
P/S ratio:
0.98
P/B ratio:
4.38%

Volume:
390.1K
Avg. volume:
352.9K
1-year change:
84.79%
Market cap:
$234.3M
Revenue:
$235.6M
EPS:
$0.45

How Much Does Puma Biotechnology Make?

Is Puma Biotechnology Growing As A Company?

  • What Is Puma Biotechnology's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.1%
  • What Is Puma Biotechnology's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Puma Biotechnology Stock Price Performance

What Is Puma Biotechnology 52-Week High & Low?

Puma Biotechnology Price To Free Cash Flow

Is It Risky To Buy Puma Biotechnology?

  • How Much Debt Does Puma Biotechnology Have?
    Total long term debt quarterly is $99.7M
  • How Much Cash Does Puma Biotechnology Have?
    Cash and short term investments quarterly total is $95.9M
  • What Is Puma Biotechnology’s Book Value Per Share?
    Book value per share is 1.12

Is Puma Biotechnology Cash Flow Positive?

  • What Is PBYI Cash Flow From Operations?
    Cash flow from operations (TTM) is $27M
  • What Is Puma Biotechnology’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Puma Biotechnology’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$19.1M

Puma Biotechnology Return On Invested Capital

  • Is Management Doing A Good Job?
    PBYI return on invested capital is 16.24%
  • What Is Puma Biotechnology Return On Assets?
    ROA measures how assets are converting to revenues and is 10.25%
  • What Is PBYI Return On Equity?
    ROE is a measure of profitability and is 63.49%

Puma Biotechnology Earnings Date & Stock Price

Puma Biotechnology Competitors

Puma Biotechnology Dividend Yield

Data Unavailable

Puma Biotechnology Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 67.74%
Revenue: 9.9% -10.77%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 4.33
Downside from Last Price: -10.84%

Major Shareholders

  • How many PBYI shares are owned by institutional investors?
    34.8M PBYI shares are owned by institutional investors
  • How many PBYI shares are owned by insiders?
    8.4M PBYI shares are owned by insiders